FY2025 EPS Estimates for RNAC Reduced by Cantor Fitzgerald
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for shares of Cartesian Therapeutics in a research note issued on Monday, May 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will earn ($3.92) per share for the year, down from their […]
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for shares of Cartesian Therapeutics in a research note issued on Monday, May 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will earn ($3.92) per share for the year, down from their […]
